Approval · Notice of Compliance 9245 · 2007
JANUVIA: Notice of Compliance 9245
Issued December 14, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9245
- Date
- December 14, 2007
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Oral antihyperglycemic agent; dpp-4 inhibitor; incretin enhancer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| JANUVIA | 02303922 | Marketed |
Medicinal ingredients
- SITAGLIPTIN PHOSPHATE MONOHYDRATE 100 MG per TAB